PrecivityAD blood test

Summary

The PrecivityAD test is a blood-based biomarker assay intended for use in the diagnosis of Alzheimer’s disease. Health Technology Wales researchers searched for evidence on the effectiveness of the PrecivityAD test in the assessment, management or diagnosis of Alzheimer’s disease.

Based on the evidence identified, HTW’s Assessment Group concluded not to progress this topic to evidence appraisal.